These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 26138831)

  • 21. Incidence and Clinical Outcomes of Stent Fractures on the Basis of 6,555 Patients and 16,482 Drug-Eluting Stents From 4 Centers.
    Kan J; Ge Z; Zhang JJ; Liu ZZ; Tian NL; Ye F; Li SJ; Qian XS; Yang S; Chen MX; Rab T; Chen SL
    JACC Cardiovasc Interv; 2016 Jun; 9(11):1115-23. PubMed ID: 27009464
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Management of drug eluting stent in-stent restenosis: A systematic review and meta-analysis.
    Goel SS; Dilip Gajulapalli R; Athappan G; Philip F; Gupta S; Murat Tuzcu E; Ellis SG; Mishkel G; Kapadia SR
    Catheter Cardiovasc Interv; 2016 May; 87(6):1080-91. PubMed ID: 26613637
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effectiveness of everolimus-eluting stents in the treatment of drug-eluting stent versus bare-metal stent restenosis.
    Almalla M; Pross V; Marx N; Hoffmann R
    Coron Artery Dis; 2012 Nov; 23(7):492-6. PubMed ID: 22990414
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical outcome of percutaneous treatment of in-stent restenosis with drug-eluting stents: results from the first phase of the prospective multicentre German DES.DE registry.
    Abdel-Wahab M; Nienaber CA; Mostafa AE; Sabin G; Tebbe U; Hochadel M; Senges J; Akin I; Kuck KH; Hamm C; Richardt G;
    EuroIntervention; 2011 Jun; 7(2):201-8. PubMed ID: 21646062
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predictor of subsequent target lesion revascularization in patients with drug-eluting stent restenosis undergoing percutaneous coronary intervention.
    Takasawa Y; Iijima R; Shiba M; Nakamura M; Sugi K
    J Cardiol; 2010 May; 55(3):391-6. PubMed ID: 20350511
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association between tissue characteristics evaluated with optical coherence tomography and mid-term results after paclitaxel-coated balloon dilatation for in-stent restenosis lesions: a comparison with plain old balloon angioplasty.
    Tada T; Kadota K; Hosogi S; Miyake K; Amano H; Nakamura M; Izawa Y; Kubo S; Ichinohe T; Hyoudou Y; Eguchi H; Hayakawa Y; Otsuru S; Hasegawa D; Shigemoto Y; Habara S; Tanaka H; Fuku Y; Kato H; Goto T; Mitsudo K
    Eur Heart J Cardiovasc Imaging; 2014 Mar; 15(3):307-15. PubMed ID: 24042176
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stent Fracture After Sirolimus-Eluting Stent Implantation: 8-Year Clinical Outcomes.
    Ohya M; Kadota K; Tada T; Habara S; Shimada T; Amano H; Izawa Y; Hyodo Y; Miyake K; Otsuru S; Hasegawa D; Tanaka H; Maruo T; Katoh H; Fuku Y; Goto T; Mitsudo K
    Circ Cardiovasc Interv; 2015 Aug; 8(8):e002664. PubMed ID: 26227346
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term clinical outcome of alternative treatment strategies for drug-eluting stents restenosis.
    Liistro F; Fineschi M; Grotti S; Angioli P; Carrera A; Ducci K; Gori T; Falsini G; Pierli C; Bolognese L
    EuroIntervention; 2009 Sep; 5(4):454-9. PubMed ID: 19755333
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of coronary anatomy and stenting technique on long-term outcome after drug-eluting stent implantation for unprotected left main coronary artery disease.
    Tiroch K; Mehilli J; Byrne RA; Schulz S; Massberg S; Laugwitz KL; Vorpahl M; Seyfarth M; Kastrati A;
    JACC Cardiovasc Interv; 2014 Jan; 7(1):29-36. PubMed ID: 24332416
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of diabetes mellitus on long-term outcomes after repeat drug-eluting stent implantation for in-stent restenosis.
    Zhao L; Zhu W; Zhang X; He D; Guo C
    BMC Cardiovasc Disord; 2017 Jan; 17(1):16. PubMed ID: 28061808
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 5-year results of a randomized comparison of XIENCE V everolimus-eluting and TAXUS paclitaxel-eluting stents: final results from the SPIRIT III trial (clinical evaluation of the XIENCE V everolimus eluting coronary stent system in the treatment of patients with de novo native coronary artery lesions).
    Gada H; Kirtane AJ; Newman W; Sanz M; Hermiller JB; Mahaffey KW; Cutlip DE; Sudhir K; Hou L; Koo K; Stone GW
    JACC Cardiovasc Interv; 2013 Dec; 6(12):1263-6. PubMed ID: 24239202
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of Drug-Eluting Stent In-Stent Restenosis With Drug-Eluting Balloons: A Systematic Review and Meta-Analysis.
    Liu S; Worme M; Yanagawa B; Kumar N; Buller CE; Cheema AN; Bagai A
    J Invasive Cardiol; 2018 Oct; 30(10):360-366. PubMed ID: 30108189
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of Clinical Results Following the Use of Drug-Eluting Balloons for a Bare-Metal Stent and Drug-Eluting Stent Instent Restenosis.
    Lee WC; Fang YN; Fang CY; Chen CJ; Yang CH; Yip HK; Hang CL; Wu CJ; Fang HY
    J Interv Cardiol; 2016 Oct; 29(5):469-479. PubMed ID: 27501848
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Decreased risk of stent fracture-related restenosis between paclitaxel-eluting stents and sirolimus eluting stents: results of long-term follow-up.
    Freixa X; Almasood AS; Khan SQ; Wainstein R; Osherov A; Mackie K; Seidelin PH; Džavík V
    Catheter Cardiovasc Interv; 2012 Mar; 79(4):559-65. PubMed ID: 21567881
    [TBL] [Abstract][Full Text] [Related]  

  • 35. First results of the DEB-AMI (drug eluting balloon in acute ST-segment elevation myocardial infarction) trial: a multicenter randomized comparison of drug-eluting balloon plus bare-metal stent versus bare-metal stent versus drug-eluting stent in primary percutaneous coronary intervention with 6-month angiographic, intravascular, functional, and clinical outcomes.
    Belkacemi A; Agostoni P; Nathoe HM; Voskuil M; Shao C; Van Belle E; Wildbergh T; Politi L; Doevendans PA; Sangiorgi GM; Stella PR
    J Am Coll Cardiol; 2012 Jun; 59(25):2327-37. PubMed ID: 22503057
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of drug-eluting balloon in patients with bare-metal or drug-eluting stent restenosis.
    Berta B; Jambrik Z; Kohar K; Szabo G; Ruzsa Z; Molnar L; Barczi G; Geller L; Becker D; Merkely B
    Hellenic J Cardiol; 2014; 55(5):369-77. PubMed ID: 25243435
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of drug-eluting balloon versus drug-eluting stent treatment of drug-eluting stent in-stent restenosis: A meta-analysis of available evidence.
    Bajraktari G; Jashari H; Ibrahimi P; Alfonso F; Jashari F; Ndrepepa G; Elezi S; Henein MY
    Int J Cardiol; 2016 Sep; 218():126-135. PubMed ID: 27232924
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Optimal treatment of recurrent restenosis lesions after drug-eluting stent implantation for in-stent restenosis lesions.
    Kubo S; Kadota K; Otsuru S; Hasegawa D; Shigemoto Y; Habara S; Tada T; Tanaka H; Fuku Y; Katoh H; Goto T; Mitsudo K
    EuroIntervention; 2013 Nov; 9(7):788-96. PubMed ID: 24280155
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of outcomes after treatment of in-stent restenosis using newer generation drug-eluting stents versus drug-eluting balloon: Patient-level pooled analysis of Korean Multicenter in-Stent Restenosis Registry.
    Lee JM; Rhee TM; Hahn JY; Hwang D; Park J; Park KW; Kim HL; Kim SH; Chae IH; Doh JH; Jeon KH; Choi YJ; Park JS; Choi SH; Gwon HC; Koo BK; Alfonso F; Kim HS
    Int J Cardiol; 2017 Mar; 230():181-190. PubMed ID: 28043660
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Drug-Coated Balloons Versus Second-Generation Drug-Eluting Stents for the Management of Recurrent Multimetal-Layered In-Stent Restenosis.
    Kawamoto H; Ruparelia N; Latib A; Miyazaki T; Sato K; Mangieri A; Contri R; Stella S; Figini F; Chieffo A; Carlino M; Montorfano M; Colombo A
    JACC Cardiovasc Interv; 2015 Oct; 8(12):1586-94. PubMed ID: 26386758
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.